# A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease

> **NCT03707730** · PHASE2 · COMPLETED · sponsor: **Igy Inc.** · enrollment: 161 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DIETARY_SUPPLEMENT:** AGY
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03707730
- **Lead sponsor:** Igy Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-29
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2024-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03707730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03707730, "A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03707730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*